News, reviews and podcasts from annual scientific meetings and symposiums around the world.
A randomized phase III clinical trial showed that many people with advanced kidney cancer can…
A large, randomized phase III trial shows that the immunotherapy pembrolizumab (Keytruda®) is a more…
Researchers conducted a retrospective analysis of consecutive, prospectively molecularly profiled patients with advanced cancer who…
An initial report from the large, ongoing Circulating Cell-Free Genome Atlas (CCGA) study provides preliminary…
“This is one more example of how immunotherapy is making steady gains against a number…
In a phase III clinical trial, a new targeted medicine, taselisib, combined with standard hormone…
A genomic study of more than 15,000 tumor samples shows that people with tumors that…
In a phase III clinical trial, a new targeted medicine, taselisib, combined with standard hormone…
A federally funded randomised study demonstrated that the use of geriatric assessment in routine care…
Rates of inherited mutations in genes other than BRCA1/2 are twice as high in breast…